BCs, such as astaxanthin and nicotinamide riboside, have been demonstrated to inhibit alcohol-induced inflammation, oxidative stress, and metabolic disorders due to their abilities to quench ROS and deacetylate the associated transcription factors through the activation of SIRT1 [30,31]. Here, SIRT1 is linked to metabolic disease.